WEBSITECHANGES

Website Changes

---

06/01/2022

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts

---

06/01/2022

Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry

---

05/31/2022

PRESENTATION AT ASCO MEETING TO SHOW ENHANCED TUMOR BREAKDOWN BY COMBINING APG-157 WITH IMMUNO-ONCOLOGY DRUGS

---

05/27/2022

FGA LEADS DIVERSE COALITION WITH LETTER SUPPORTING THE PROMISING PATHWAY ACT

---

05/27/2022

Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma

---

05/27/2022

Immunomic Therapeutics CEO expects meaningful test results for brain tumor drug

---

05/27/2022

We respond to “promising” survival data from phase III trial of DCVax®-L

---

05/27/2022

Our next webinar has been postponed!

---

05/24/2022

Shortage of contrast dye forcing hospitals world-wide to ration, and delay procedures

---

05/21/2022

Musella Foundation webinar this Sunday 5/22/22 has been postponed!

---

05/19/2022

GT Medical Technologies Announces the Presentation of Clinical Data on GammaTile® Therapy in the Treatment of Recurrent Glioblastomas at the 2022 American Association of Neurological Surgeons Scientific Meeting

---

05/19/2022

Musella Foundation Brain Tumor Awareness Month Webinars!

---

05/19/2022

Clark, NJ National Walks to End Brain Tumors - 5K Walk/Run on July 24, 2022

---

05/19/2022

Take a stand for those who can’t with the Promising Pathway Act

---

05/16/2022

Musella Foundation Co-payment Assistance Program is now CLOSED to new patients

---

05/16/2022

Webinar video about `How to speed up the search for the cure of brain tumors` posted to website!

---

05/16/2022

Cancer Commons Presents Free Educational Webinar for Caregivers May 18, 2022

---

05/13/2022

Musella Foundation Copay Assistance program is running low on funding

---

05/13/2022

DCVax-L Phase 3 Clinical Trial Results - Video Posted!

---

05/13/2022

National Walks To End Brain Tumors This Weekend!

---

05/13/2022

Musella Foundation Brain Tumor Awareness Month Webinar Series!

---

05/12/2022

Mount Sinai Neurosurgeon Elected as First Female Chair of North America’s Preeminent Brain Tumor Association

---

05/11/2022

FDA Recommends Early Progression to Phase 3 Trials for Sitoiganap for Glioblastoma Treatment

---

05/10/2022

The long awaited results of the double blind, randomized, placebo controlled Phase III clinical trial with DCVax-L for newly diagnosed GBM was just released! The slides of the results presentation are now on my website at virtualtrials.org/dcvax #GBM #BTAM #DCVAX

---

05/08/2022

Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter

---